@FiercePharma: ADHD diagnoses up 24% over past 10 years; study author cites "better diagnosis" and possible "upward trend." More | Follow @FiercePharma
@AlisonBFierce: Vanderbilt University has emerged as a leading institution for central nervous system drug research and discovery. Editor's Corner | Follow @AlisonBFierce
@EricPFierce: Plant problems stymie Impax NDA for Parkinson drug, FDA says. Article | Follow @EricPFierce
> GlaxoSmithKline ($GSK) and independent researchers continue to probe a possible link between the pandemic flu shot Pandemrix and hundreds of cases of narcolepsy. Report
> European regulators asked Arena Pharmaceuticals ($ARNA) to "further justify" the safety and efficacy of its weight-loss drug Belviq, which awaits a recommendation from the Committee for Medicinal Products for Human Use. Report
> GlaxoSmithKline is cutting the calories and sugar in its energy and nutrition drinks Lucozade and Ribena, as part of a government plan to fight obesity. Report
> Italy's Recordati wrapped up its $100 million buyout of a portfolio of Lundbeck's U.S. product rights, including Panhematin and NeoProfen. Release | Report
> The number of children diagnosed with Attention Deficit Hyperactivity Disorder rose by 24% over the past decade, partly because of improved diagnosis, a JAMA Pediatrics study found. Report
@FierceMedDev: J&J device revenue jumped 6.4% in 2012 thanks to Synthes buy. Report | Follow @FierceMedDev
@DamianFierce: If $LIFE is indeed for sale, that's not stopping it from pursuing more M&A of its own. More | Follow @DamianFierce
> Welch Allyn snags FDA clearance for iPhone-friendly eye scope. Article
> Invacare closes $150M unit sale as it reels from FDA fallout. Story
Biotech News
@FierceBiotech: Novo Nordisk nabs European OK on blockbuster diabetes drug hopeful. News | Follow @FierceBiotech
@JohnCFierce: As CRL letters go, Impax would seem to have a low hurdle ahead on its sustained release Parkinson's drug. More | Follow @JohnCFierce
@RyanMFierce: Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article | Follow @RyanMFierce
> New $80M venture fund to back startups entering 'valley of death.' Story
> Biotech vet Astley-Sparke takes U.S. lead for pioneering gene therapy player. Article
Biotech IT News
> New chief named for Perceptive Informatics. Story
> U.K. regulator finds social media groove…finally. Item
> Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article
> Elsevier rumored as potential buyer of open science startup. News
CRO News
> Is GlaxoSmithKline stretching its contractors too thin? Story
> Covance teams with U.K.'s NHS Trust on Phase I trials. Report
> Clinipace rejiggers eClinical platform. Article
> Quintiles lands pathology accreditation for Indian lab. News
Pharma Manufacturing News
> BASF lands Pronova making it a top omega-3 maker. Report
> Pfizer to develop laser cleaning verification system. Item
> Cargo theft down in year of key arrests. News
> Plant problems stymie Impax NDA, FDA says. Article
Biotech Research News
> Calcium receptor could stop sleeping sickness in its tracks. Item
> Oral breast cancer vaccine could prevent recurrence. Article
> A great leap forward: Microdystrophin gene therapy success in dogs. Report
> Glowing mice could blaze way for detecting, tracking cancer growth. News
And Finally... Doctors need better training in talking about new drugs to their patients, a study found. Report